BioCorRx (BICX) Depreciation & Amortization - Total (2013 - 2026)

BioCorRx has disclosed Depreciation & Amortization - Total across 14 years of filings, most recently posting $2610.0 for Q1 2026.

• Depreciation & Amortization - Total for Q1 2026 came in at $2610.0, down 30.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $15132.0 (down 48.37% YoY), and the FY2025 annual result was $14915.0, down 53.34% from the prior year.
• Depreciation & Amortization - Total came in at $2610.0 for Q1 2026 at BioCorRx, down from $6918.0 in the prior quarter.
• In the past five years, Depreciation & Amortization - Total ranged from a high of $12708.0 in Q4 2024 to a low of $1474.0 in Q3 2025.
• The 5-year median for Depreciation & Amortization - Total is $6420.0 (2023), against an average of $6044.8.
• Across the five-year window, Depreciation & Amortization - Total surged 97.94% in 2024 and slumped 77.04% in 2025, its largest moves.
• BioCorRx's Depreciation & Amortization - Total stood at $6567.0 in 2022, then declined by 2.24% to $6420.0 in 2023, then soared by 97.94% to $12708.0 in 2024, then sank by 45.56% to $6918.0 in 2025, then sank by 62.27% to $2610.0 in 2026.
• The last three Depreciation & Amortization - Total figures came in at $2610.0 (Q1 2026), $6918.0 (Q4 2025), and $1474.0 (Q3 2025), per Business Quant data.